Nencioni A - Search Results

1

Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results.

Castagnino N, Tortolina L, Balbi A, Pesenti R, Montagna R, Ballestrero A, Soncini D, Moran E, Nencioni A, Parodi S. Castagnino N, et al. Among authors: nencioni a. Curr Cancer Drug Targets. 2010 Nov;10(7):737-57. doi: 10.2174/156800910793605848. Curr Cancer Drug Targets. 2010. PMID: 20578981

2

Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination.

Ballestrero A, Coviello DA, Garuti A, Nencioni A, Famà A, Rocco I, Bertorelli R, Ferrando F, Gonella R, Patrone F. Ballestrero A, et al. Among authors: nencioni a. Cancer. 2001 Oct 15;92(8):2030-5. doi: 10.1002/1097-0142(20011015)92:8<2030::aid-cncr1541>3.0.co;2-g. Cancer. 2001. PMID: 11596016

3

Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer.

Nencioni A, Müller MR, Grünebach F, Garuti A, Mingari MC, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Cancer Gene Ther. 2003 Mar;10(3):209-14. doi: 10.1038/sj.cgt.7700557. Cancer Gene Ther. 2003. PMID: 12637942

4

Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.

Ballestrero A, Nencioni A, Boy D, Rocco I, Garuti A, Mela GS, Van Parijs L, Brossart P, Wesselborg S, Patrone F. Ballestrero A, et al. Among authors: nencioni a. Clin Cancer Res. 2004 Feb 15;10(4):1463-70. doi: 10.1158/1078-0432.ccr-1365-02. Clin Cancer Res. 2004. PMID: 14977850

5

Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.

Ballestrero A, Garuti A, Bertolotto M, Rocco I, Boy D, Nencioni A, Ottonello L, Patrone F. Ballestrero A, et al. Among authors: nencioni a. Br J Cancer. 2005 May 23;92(10):1948-52. doi: 10.1038/sj.bjc.6602563. Br J Cancer. 2005. PMID: 15841077 Free PMC article.

6

Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells.

Nencioni A, Garuti A, Schwarzenberg K, Cirmena G, Dal Bello G, Rocco I, Barbieri E, Brossart P, Patrone F, Ballestrero A. Nencioni A, et al. Eur J Immunol. 2006 Mar;36(3):681-9. doi: 10.1002/eji.200535298. Eur J Immunol. 2006. PMID: 16479541 Free article.

7

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation.

Nencioni A, Schwarzenberg K, Brauer KM, Schmidt SM, Ballestrero A, Grünebach F, Brossart P. Nencioni A, et al. Blood. 2006 Jul 15;108(2):551-8. doi: 10.1182/blood-2005-08-3494. Epub 2006 Mar 14. Blood. 2006. PMID: 16537813 Free article.

8

Proteasome inhibitors: antitumor effects and beyond.

Nencioni A, Grünebach F, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Leukemia. 2007 Jan;21(1):30-6. doi: 10.1038/sj.leu.2404444. Epub 2006 Nov 9. Leukemia. 2007. PMID: 17096016 Review.

9

The proteasome and its inhibitors in immune regulation and immune disorders.

Nencioni A, Grunebach F, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Crit Rev Immunol. 2006;26(6):487-98. doi: 10.1615/critrevimmunol.v26.i6.20. Crit Rev Immunol. 2006. PMID: 17341190 Review.

10

Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity.

Nencioni A, Beck J, Werth D, Grünebach F, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Clin Cancer Res. 2007 Jul 1;13(13):3933-41. doi: 10.1158/1078-0432.CCR-06-2903. Clin Cancer Res. 2007. PMID: 17606727 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters